Loading company…
Noscira develops biotechnology treatments for neurodegenerative diseases.
Noscira researches and develops therapeutics for neurodegenerative diseases. Founded in 2000, the biotechnology company is based in Madrid, Spain. It raised EUR 19.36 million in funding on January 12, 2011, from AXIS Participaciones and SuanFarma.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in